
Sign up to save your podcasts
Or


For those living with epilepsy, a life without seizures truly is freedom.
In this podcast, hosts Cadence Neuroscience CEO Kent Leyde and Chief Scientific Officer Doug Sheffield discuss their work toward ending epileptic seizures.
From their own innovative medical technology to other advances in the field, Kent and Doug's conversations with guests investigate the impact epilepsy has and the work being done locally and globally to ensure every person lives a seizure-free life.
Learn more at cadenceneuro.com.
Cadence Neuroscience is developing investigational medical technologies that have not been approved or cleared by the U.S. Food and Drug Administration (FDA) or other health authorities. Any forward-looking statements reflect current expectations and are subject to risks and uncertainties. Actual results may differ materially. This information is for educational purposes only and does not constitute medical advice or investigational device promotion. Patients should consult qualified healthcare providers regarding diagnosis and treatment options.
Currently, these investigational technologies are only accessible through participation in a clinical trial. To learn more about these investigational technologies and how to access them, talk with your qualified healthcare provider or visit www.clinicaltrials.gov.
By Kent Leyde, Doug SheffieldFor those living with epilepsy, a life without seizures truly is freedom.
In this podcast, hosts Cadence Neuroscience CEO Kent Leyde and Chief Scientific Officer Doug Sheffield discuss their work toward ending epileptic seizures.
From their own innovative medical technology to other advances in the field, Kent and Doug's conversations with guests investigate the impact epilepsy has and the work being done locally and globally to ensure every person lives a seizure-free life.
Learn more at cadenceneuro.com.
Cadence Neuroscience is developing investigational medical technologies that have not been approved or cleared by the U.S. Food and Drug Administration (FDA) or other health authorities. Any forward-looking statements reflect current expectations and are subject to risks and uncertainties. Actual results may differ materially. This information is for educational purposes only and does not constitute medical advice or investigational device promotion. Patients should consult qualified healthcare providers regarding diagnosis and treatment options.
Currently, these investigational technologies are only accessible through participation in a clinical trial. To learn more about these investigational technologies and how to access them, talk with your qualified healthcare provider or visit www.clinicaltrials.gov.